RESPONSE TO NEOADYAVANT CHEMOTHERAPY WITH PLATINUM-BASED DRUGS IN BREAST CANCER PATIENTS WITH BRCA1 DELETION IN TUMOR

M. M. Tsyganov; N. A. Tarabanovskaya; I. V. Deryusheva; M. K. Ibragimova; P. V. Kazantseva; A. M. Pevzner; E. M. Slonimskaya; N. V. Litviakov

Siberian journal of oncology
Sibirskij onkologičeskij žurnal

ISSN 1814-4861 (Print)
ISSN 2312-3168 (Online)

User

eng | рус

Siberian journal of oncology

Advanced search

Archives

Download this PDF file

Fullscreen

For citations:

Tsyganov M.M., Tarabanovskaya N.A., Deryusheva I.V., Ibragimova M.K., Kazantseva P.V., Pevzner A.M., Slonimskaya E.M., Litviakov N.V. RESPONSE TO NEOADYAVANT CHEMOTHERAPY WITH PLATINUM-BASED DRUGS IN BREAST CANCER PATIENTS WITH BRCA1 DELETION IN TUMOR. Siberian journal of oncology. 2019;18(3):103-108. (In Russ.) https://doi.org/10.21294/1814-4861-2019-18-3-103-108

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 1814-4861 (Print)
ISSN 2312-3168 (Online)

Editor-in-Chief

Evgeny L. Choynzonov

* not an advertisement

Indexing Databases

* not an advertisement

Popular articles

Notifications

Article Tools

Finding References

Email this article (Login required)

Email the author (Login required)

About the Authors

M. M. Tsyganov
Tomsk National Research Medical Center, Russian Academy of Sciences
Russian Federation

Matvey M. Tsyganov, PhD, Researcher, Laboratory of Oncovirology, Cancer Research Institute

5, Kooperativny Street, 634050-Tomsk

Researcher ID (WOS): A-7212-2014.

Author ID (Scopus): 55366377400

N. A. Tarabanovskaya
Tomsk National Research Medical Center, Russian Academy of Sciences
Russian Federation

Natalia A. Tarabanovskaya, MD, PhD, Junior Researcher, Department of General Oncology, Cancer Research Institute

5, Kooperativny Street, 634050-Tomsk

Researcher ID (WOS): R-5596-2017.

Author ID (Scopus): 56324452500

I. V. Deryusheva
Tomsk National Research Medical Center, Russian Academy of Sciences
Russian Federation

Irina V. Deryusheva, Junior Researcher, Laboratory of Oncovirology, Cancer Research Institute

5, Kooperativny Street, 634050-Tomsk

Researcher ID (WOS): Q-5607-2017.

Author ID (Scopus): 57194535404

M. K. Ibragimova
Tomsk National Research Medical Center, Russian Academy of Sciences; The National Research Tomsk State University
Russian Federation

Marina K. Ibragimova, Junior Researcher, Laboratory of Oncovirology, Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences